TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: functional connectivity based on weighted pairwise phase consistency (wPPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perceived barriers to BSE practice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Any breastfeeding rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of IV therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Episodes of extravasation
Endpoint domain: Adverse events/effects
Primary endpoint: reduced functional connectivity of limbic structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvement in pVAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: size of calcifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for additional treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mortality from salvage therapy
Endpoint domain: Mortality/survival
Primary endpoint: Severity and level of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Hospitalizations for myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospitalizations for stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospitalizations for major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dysphagia scores (DSQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to weight loss diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Experiencing harassment related to race or ethnicity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfaction with reporting discrimination and harassment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: short-term pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score for the analytic question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epidermal and dermal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical evaluation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability and downtime
Endpoint domain: Adverse events/effects
Primary endpoint: energy purchased in worksite cafeterias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mild/moderate adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: total amount of tooth movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postendodontic pain incidence and intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to last dose of parenteral opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CV-related hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in sensation on pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAFPAS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to purchase fast food
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Preferences for fast food
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Attitudes to sponsor brands
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: positive affectivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-reported avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volume of fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of intrahepatic colorectal liver metastases identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score from clinical practice skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation during application
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Application and exam anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent change in type I FCSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knowledge about treatment elements
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: nutrition self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: physical activity self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: physical activity strategies
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fasting serum total cholesterol (TC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fasting serum triacylglycerol (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fasting serum high-density lipoprotein (HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average healing stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete resolution of MBRSs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimal lumen area (MLA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: central line‐associated bloodstream infections
Endpoint domain: Adverse events/effects
Primary endpoint: utilization rates of mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: utilization rates of central venous catheter
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: skeletal changes in the nasal cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletal changes in the nasal floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletal changes in the maxilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stretching time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of stroke
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ED fears
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid consumption before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of being discharged home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change from baseline FEV1 at 2 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Association of HDL with DLBCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Association of HDL with MZL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Association of TG with MZL risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of transient hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite of death, myocardial infarction, any stroke, or systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: serious cardiovascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cognitive functions (omission T‐scores, hit reaction time T‐scores, hit reaction time standard error T‐scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in Body Weight (BW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Weight (BW) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic Blood Pressure (SBP) change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung volume change over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Predictive efficiency of the Combined Model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of drug trial implementation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: moderate-to-severe functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: clinical levels of distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS-2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychological preparedness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1200 cc urine for 24 hours by 28 days posttransplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative endoscopy to assess recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VBF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MYMOP scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FEAR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rs-FC between left lateral PFC and primary sensorimotor cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: performance changes after training
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fever anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dye penetration depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: c-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: walking pain scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of ketosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 36 months stoma free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total in hospital days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: parastomal hernias
Endpoint domain: Adverse events/effects
Primary endpoint: NAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FIB-4 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Recurrent Running Injuries (RRIs)
Endpoint domain: Mortality/survival
Primary endpoint: all-cause death or clinical deterioration
Endpoint domain: Mortality/survival
Primary endpoint: TWHS AF difference between products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ulnar variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volar tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TAEs and GDs
Endpoint domain: Adverse events/effects
Primary endpoint: Nicotine removal effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of sleep medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean SBP increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean DBP increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of elevated blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differences in efficacy between M-MAT and CIAT-Plus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal isometric voluntary force to ankle plantarflexion (MIVFp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of sleep quality (DDSQ50)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total sleep time (DDTST50)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reduction in cognitive distortions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Navigation effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgeons' perception of AR visualization helpfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AR depth information and accuracy rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state responses of cortico-cortical evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in range 70-180 mg/dL (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Iodine excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iodine balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periacetabular BMD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for anxiolytics and analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median pain score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of cognitive impairments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decrease in the severity of thrombocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cpm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognition measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Positive attitude towards telenursing and telehealth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: accuracy in the classification of prostatitis types
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appetite sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eating behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rate of measles antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate of rubella antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometrical mean concentration (GMC) of measles antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometrical mean concentration (GMC) of rubella antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of siblings screened
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of glaucoma among siblings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the composite score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of progression to late AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing childhood asthma
Endpoint domain: Mortality/survival
Primary endpoint: NIHSS neurologic deficit severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cystoid space area decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of SFAs in plasma over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hormonal control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FLS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ΔFRE (Delta Fluoride Release)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LH pulsatility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prediction of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS stress level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in patients' alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of cardiovascular death, recurrent MI, cardiogenic shock, or NYHA class IV heart failure
Endpoint domain: Mortality/survival
Primary endpoint: worsening HF or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Intestinal barrier permeability parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anxiety at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: stress at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly METs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slowed eGFR slope decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lowered risk of persistent eGFR reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increased odds of referral due to fundus photography findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Cobalamin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intraislet capillary density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: terminal hair regrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual cognitive arousal after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal reports of poor infant sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Self-management behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical activity stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical fitness components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: void trial failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: spontaneous birth between 24+0 and 33+6 weeks’ gestation
Endpoint domain: Mortality/survival
Primary endpoint: miscarriage or spontaneous preterm birth between randomization and 31+6 weeks’ gestation
Endpoint domain: Mortality/survival
Primary endpoint: MMN amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MMN frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of MT10107 compared to onabotulinum toxin A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Routine Assessment of Patient Index Data 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family-assessed FAST
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Affordability of recommended diets
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Food stress in low-income families
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of peri-implantitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of cognitive function (ADAS-Jcog subscale 'orientation')
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Suppression of brain atrophy progression (VSRAD scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Type 2 diabetes mellitus (T2DM)
Endpoint domain: Mortality/survival
Primary endpoint: Quality of interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inattention scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hyperactivity scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ulcer healing rate at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical changes and daily living enhancements
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: number of tooth sectioning steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes